Brief: Bergenbio Q2 Oper Loss Widens To NOK 92.3 Mln

Oncoinvent ASA

17/08/2021 06:14

Aug 17 (Reuters) - Bergenbio ASA  BGBIO.OL :
    * BERGENBIO ASA: RESULTS FOR THE SECOND QUARTER AND FIRST
HALF OF
2021
    * Q2 REVENUE AMOUNTED TO NOK 0.0 MILLION (NOK 0.0 MILLION)
    * Q2 TOTAL OPERATING EXPENSES FOR Q2 WERE NOK 92.3 MILLION
(NOK
64.7 MILLION)
    * Q2 OPERATING LOSS FOR Q2 OF NOK 92.3 MILLION (NOK 64.7
MILLION)

Source text for Eikon:  ID:nWkr36Lh95 
Further company coverage:  BGBIO.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))